Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression

Enhancer of zeste homolog 2 (EZH2), an oncogene, is a commonly up‐regulated epigenetic factor in human cancer. Hepatocellular carcinoma deletion gene 1 (DLC1) is an antioncogene that is either expressed at low levels or not expressed in many malignant tumours. Curcumin is a promising anticancer drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xueliang, Jiao, Dechao, Dou, Mengmeng, Zhang, Weijie, Lv, Liying, Chen, Jianjian, Li, Lifeng, Wang, Liuxing, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521266/
https://www.ncbi.nlm.nih.gov/pubmed/32725802
http://dx.doi.org/10.1111/jcmm.15683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521266/
https://www.ncbi.nlm.nih.gov/pubmed/32725802
http://dx.doi.org/10.1111/jcmm.15683

Ejemplares similares